Spacer

Aerial view of the NIH Clinical Center buildings.

Research Staff

Gwen Wallen

Gwenyth R. Wallen, PhD, RN   
Section Chief, Nursing Research & Translational Science

Gwenyth Wallen, RN, PhD is currently the Chief of Nursing Research and Translational Science at the National Institutes of Health, Clinical Center. Her clinical research specializations include health behavior and health disparities research with special emphasis on methodology and measurement in end-of-life care, integrative health and vulnerable populations. Prior to beginning her career as a clinical nurse scientist she held advance practice roles as the Clinical Specialist for Neonatology and Clinical Manager of the Level III NICU at the Washington Hospital Center, in Washington, DC. Dr. Wallen also served as a post-doctoral research associate in the Department of Family Studies at the University of Maryland coordinating evaluation research for three state and local Responsible Fatherhood programs.

Dr. Wallen is a member of the NICHD Institutional Review Board. She has served as an Adjunct Assistant Professor at Georgetown University School of Nursing and Health Studies where she taught a graduate course in measurement and research methodology. Dr. Wallen has a BS in Nursing from the University of Maryland, a MA in Management and Supervision from Central Michigan University, and a PhD in Health Education from the University of Maryland. In 2008 she completed the 2-year University of Arizona Fellowship in Integrative Medicine as part of her developing portfolio of integrative health research.

Current research activities:

Principal Investigator: 03-CC-0301 Health Beliefs and Health Behavior Practices, Including Complementary and Alternative Medicine Use, Among Minorities with Rheumatic Disease.

Associate Investigator: 04-CC-0070 Exploring Patient-Provider Trust Among Individuals with End-Stage Renal Disease

Principal Investigator: 07-CC-0011 Hypnosis as a Pain and Symptom Management Strategy in Patients with Sickle Cell Disease

Associate Investigator: 11-CC-0083 Beyond Intuition: Quantifying and Understanding the Signs and Symptoms of Fever

line

Margaret BevansLCDR Margaret F. Bevans PhD, RN, AOCN
Clinical Nurse Scientist   

LCDR Margaret Bevans is a Clinical Nurse Scientist with Nursing Research & Translational Science within Nursing and Patient Care Services. The objective of her clinical research is to translate theoretical and experiential knowledge into effective interventions to improve the health outcomes of cancer patients, specifically hematopoietic stem cell transplantation (HSCT) recipients and their caregivers. Prior to beginning her career as a clinical nurse scientist she completed her post-doctoral research in collaboration with The Catholic University School of Social Services testing the feasibility of a cognitive behavioral education intervention in cancer family caregivers. Her research expertise extends to understanding the practice of HSCT nursing and its implications on patient and family outcomes as well as survey methodology and measurement.

Dr. Bevans received her B.S. from Johns Hopkins University in Baltimore, Maryland in 1986 and started her career at the NIH in 1988. She began working in Hematology & Blood and Marrow Transplantation (BMT) in 1992. Dr. Bevans’ graduate education was at the University of Maryland receiving her MS in 1993 and her PhD in 2005. Dr. Bevans has received the Josh Gottheil Memorial BMT Career Development award from the Oncology Nursing Society, the RADM Faye G. Abdellah Award for Nursing Research and an NIH Directors award for her continued efforts to improve the practice of BMT. She has been a member of the National Heart, Lung, and Blood IRB since 1997 and a member of the NIH Intramural BMT Consortium.

Clinical Center Grand Rounds Lecture Series- May 4, 2011
"Measuring Stress and It's Impact on Family Caregivers" Flash icon (256 K)

Current research activities:Caregivers Logo

Principal Investigator: 08-CC-0220 - A Phase II clinical trial to determine the effectiveness of problem solving education in caregivers and patients during allogeneic HSCT

Associate Investigator: 10-CH-0083 A Phase I Trial of Safety and Immunogenicity of Gardasil (Registered Trademark) Vaccination Post Stem Cell Transplantation in Patients With and Without Immunosuppression

Principal Investigator: 07-CC-N046 (00-CC- 0002) - Quality of Life in Patients Undergoing a Non-myeloablative versus a Myeloablative allogeneic PBSC Transplant for Hematological Disease

Principal Investigator: 05-CC-0216 - Prospective Assessment of Functional Status, Psychosocial Adjustment, Health Related Quality of Life and the Symptom Experience in Patients Treated with Allogeneic Hematopoietic Stem Cell Transplantation

Associate Investigator: 05-H-0130- Long-term Evaluation and Follow-up Care of Patients Treated With Stem Cell Transplants

Principle Investigator: 2010 OHSR #5246 - Clinical Research Nurse (CRN) Role Delineation Survey Study   


Note: Adobe Flash requires the Adobe Flash Player to run.

 

Nursing Research Staff

Gwenyth R. Wallen

LCDR Margaret F. Bevans

CCNIH
HHSUSA.gov